Mary Weger

2013 - Aegerion Pharmaceuticals

In 2013, Mary Weger earned a total compensation of $1.5M as former Chief Performance Officer at Aegerion Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$168,000
Option Awards$1,025,343
Salary$320,000
Total$1,513,343

Weger received $1M in option awards, accounting for 68% of the total pay in 2013.

Weger also received $168K in non-equity incentive plan and $320K in salary.

Rankings

In 2013, Mary Weger's compensation ranked 4,893rd out of 12,286 executives tracked by ExecPay. In other words, Weger earned more than 60.2% of executives.

ClassificationRankingPercentile
All
4,893
out of 12,286
60th
Division
Manufacturing
1,691
out of 4,612
63rd
Major group
Chemicals And Allied Products
486
out of 1,462
67th
Industry group
Drugs
342
out of 1,156
70th
Industry
Pharmaceutical Preparations
273
out of 890
69th
Source: SEC filing on April 29, 2016.

Weger's colleagues

We found four more compensation records of executives who worked with Mary Weger at Aegerion Pharmaceuticals in 2013.

2013

Marc Beer

Aegerion Pharmaceuticals

Chief Executive Officer

2013

Mark Sumeray

Aegerion Pharmaceuticals

Chief Medical Officer

2013

Mark Fitzpatrick

Aegerion Pharmaceuticals

Chief Financial Officer

2013

Martha Carter

Aegerion Pharmaceuticals

Chief Regulatory Officer

In-depth

You may also like